William G. Nelson, MD, PhD
Articles
Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer: Part 2
Alan W. Partin, MD, PhD;Gerald E. Hanks, MD;Eric A. Klein, MD;Judd W. Moul, MD;William G. Nelson, MD, PhD;Howard I. Scher, MD
September 1st 2002Despite the impact of prostate-specific antigen (PSA) testing on the detection and management of prostate cancer, controversy about its usefulness as a marker of disease activity continues. This review, based on a
Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer: Part 1
Alan W. Partin, MD, PhD;Gerald E. Hanks, MD;Eric A. Klein, MD;Judd W. Moul, MD;William G. Nelson, MD, PhD;Howard I. Scher, MD
August 1st 2002Despite the impact of prostate-specific antigen (PSA) testing on the detection and management of prostate cancer, controversy about its usefulness as a marker of disease activity continues. This review, based on a
Latest Updated Articles
Published: January 24th 2025 | Updated: February 6th 2025
FDA Approves Treosulfan Combo Injection for HSCT Conditioning in AML/MDS
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: April 30th 2011 | Updated: July 26th 2025
Photosensitive Facial Rash Depicted Along with Polyarticular Arthralgias
